Monthly Archives: June 2025

Ep 39 – Robotic Surgery’s Past, Present, and Future: A Conversation with Dr. Jean Joseph



Today’s “Prostate Cancer and You” podcast features Dr. Jean Joseph, chairman of the department of urology at the University of Rochester Medical Center and keynote at the May 2025 MPCC Symposium. In this conversation with host Jordan Rich, Dr. Joseph furthers his keynote topics, discussing the history, benefits, and future development of robotic surgery for prostate cancer. The technology, initially developed for cardiac surgery, is less invasive than traditional surgery and has significantly reduced complications and side effects, allowing for a quicker recovery. 

Jean V. Joseph, MD, is W.W. Scott Professor and chairman of the department of urology at the University of Rochester Medical Center. He specializes in robotic surgery for urologic diseases, particularly prostate cancer. His research interests include surgical innovation, applications of novel robotic technology, and patient outcomes. Dr. Joseph completed a master class in laparoscopic prostatectomy at the Institute Mutualiste Montsouris (Paris, France) and holds a master’s in business administration from the Rochester Institute of Technology. 


Part II: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know



In this second of a two-part podcast episode detailing new treatments for prostate cancer, Dr. Phillip Davis and Dr. Dan Stevens highlight the increasing accessibility of molecular imaging and radioligy and therapy across the US and the potential for earlier use of these technologies. They also discuss the promise of future advancements including personalized cancer treatments, the use of new radioactive isotopes, and the integration of AI in imaging and workflows. Both doctors stress the rapid developments in prostate cancer detection and treatment, encouraging patients to stay informed and involved in their care.


Part I: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know



In this first of a two-part podcast episode, Dr. Phillip Davis and Dr. Dan Stevens follow up on the symposium topic of “New Treatments for Prostate Cancer.” In Part I, Dr. Philip Davis explains molecular imaging, which uses a low dose of radioactive medicine to detect cancer and other diseases early, as well as providing doctors with both anatomic and functional information on the cancer cells. Dr. Dan Stevens details radioligy and therapy, which uses radioactive isotopes to target cancer cells more precisely than traditional radiation therapy. Both technologies offer improved treatment options, enhancing patient outcomes.